Farnesoid X receptor functions in cervical cancer via the p14 < sup > ARF < /sup > -mouse double minute 2-p53 pathway

CONCLUSIONS: FXR inhibits cervical cancer by upregulating the p14ARF-MDM2-p53 pathway. Activation of FXR may be a potential strategy for the treatment of cervical cancer.PMID:35347542 | DOI:10.1007/s11033-022-07201-x

Source: Molecular Biology Reports - March 29, 2022 Category: Molecular Biology Authors: Xiaohua Huang Bin Wang Huimin Shen Danmei Huang Ganggang Shi Source Type: research